BPC-157 + TB-500 · tendons, joints, soft-tissue
Recover like the science says you can.
The peptides circulating in private athlete groups for the last decade — BPC-157 for vascularization and gut repair, TB-500 for systemic tissue turnover — now prescribed by a licensed physician and shipped pharmaceutical-grade from a 503B compounding pharmacy. No more sketchy lab sourcing. No more reconstituting at the kitchen counter.
For the lifelong athlete with the joint that never quite recovered.
Licensed physicians
8-state coverage
503B compounding pharmacy
FDA-registered, cGMP-compliant
Cold-chain validated
2–8°C door-to-door
Refundable consult
If the physician declines
First month bundle
$249
Consult + first month’s prescription. Refills $179/mo · about $8.30/day
- Async consult with a licensed physician
- Prescription written + filled at a 503B compounding pharmacy
- Cold-chain reconstituted BPC-157 + TB-500 vials
- Conduit pen + 30 pen needles
- Conduit+ membership while you run the protocol
Refundable consult if the physician declines.
Why people pick this
“The Achilles flared every six months for eight years. I'd done PRP twice. The 12-week protocol Conduit's physician wrote for me is the first thing that's actually stuck.”
Conduit Care user · Recovery protocol
The mechanism, in plain English.
BPC-157 is a pentadecapeptide derived from a protein in human gastric juice. Animal studies — over 200 of them — consistently show acceleration of tendon-to-bone healing, ligament repair, and gut-barrier restoration. TB-500 (a thymosin beta-4 fragment) up-regulates actin to drive cell migration into damaged tissue. The two stack covers different mechanisms of the same repair cascade.
- NoteBPC-157 accelerates Achilles tendon-to-bone healing in controlled animal models (Cerovecki et al., 2010)
- NoteTB-500 promotes endothelial cell migration and angiogenesis (Goldstein et al., 2012)
- NoteCommunity-cited protocols: BPC 250 mcg daily SC, TB-500 2–5 mg weekly
- NoteNo FDA-approved indication. Conduit Care operates within compounded-product framework with licensed physician oversight.
What changes, and when.
01 · Week 1–2
Cold-chain shipment arrives. Lite intake completed. First dose logged with the Conduit pen.
02 · Week 4
Most users report softer onset of chronic flares. Track pain scores and inflammation markers in the app.
03 · Week 8
Reassessment with the reviewing physician. Adjust dose, hold, or continue based on response.
04 · Week 12
Common cycle endpoint. Many users return for a second cycle 6–8 weeks later for maintenance.
Three ways to run recovery.
Do nothing
Status quo.
- · No risk, no result
- · Hope it resolves on its own
- · No data captured
- · $0 / month
Self-source
Research-supply gamble.
- · Unverified source + COA
- · No physician oversight
- · Reconstitute yourself
- · Maybe $100–200 / month
Conduit Care
Pharma-grade.
- · 503B pharmacy + COA
- · Physician-supervised
- · Cold-chain shipped, pen-ready
- · $179/mo refill
The physician
Licensed in your state.
Your case is reviewed asynchronously by a physician licensed in your state of residence. They evaluate your medical history, current medications, and contraindications against the requested protocol. They approve, decline, or request more information. They are accountable for the prescription.
24-hour median response
The pharmacy
503B compounding.
An FDA-registered 503B outsourcing facility fills your prescription. cGMP-compliant production. Lot-tracked vials. USP <797> sterile compounding standards. Validated 2–8°C cold-chain transit from the fill line to your door.
FDA-registered, cGMP-compliant
Before you start.
- How is this different from buying research peptides online?
- A licensed physician reviews your medical history and writes a prescription before anything ships. A 503B compounding pharmacy fulfills the prescription — meaning FDA-registered facility, cGMP-compliant production, validated cold-chain transit. Research-supply sites operate without prescription oversight or pharmacy-grade fulfillment. The product, the process, and the accountability are categorically different.
- How long does the review take?
- Most cases are reviewed within 24 hours. The physician may approve, request more information, or decline based on contraindications. If declined, the consult fee is refunded in full.
- Is this telehealth or in-person?
- Asynchronous telehealth only. You complete an intake form, upload an ID, the physician reviews on their own schedule. No video visit required. You can complete the entire intake in under five minutes and the physician responds in under 24 hours.
- What if I already use insulin syringes and vials?
- You can still use Conduit. The Conduit pen accepts the cold-chain reconstituted vials we ship — no draws, no math. If you prefer to keep using syringes, you can buy the pen separately on /shop. The Conduit app tracks doses either way.
- What states do you ship to?
- Conduit Care is currently live in Texas, Tennessee, Oklahoma, Louisiana, Arizona, Georgia, Florida, and New York. Coverage depends on physician licensure and pharmacy reach. We expand quarterly. If your state isn’t live yet, the waitlist is the fastest way to know when it goes live.
Not a guarantee.
Not for everyone.
- · The reviewing physician determines dose, duration, and eligibility based on your intake. They may decline.
- · Recovery protocols are not FDA-approved indications for these peptides. Conduit Care operates within compounded- product framework with licensed physician oversight.
- · Outcomes vary. Conduit doesn’t make therapeutic claims; the platform supports adherence and tracking.
- · Consult fee is refundable if the physician declines. Prescription cost is not refundable once filled.
Working on something else?
Ready
Start your recovery protocol.
A licensed physician reviews in under 24 hours. Refundable if declined.
Conduit products are sterile fluid transfer devices intended for research applications. Conduit Care is a separate asynchronous telehealth service. Not intended for diagnosis, treatment, or prevention of any disease. The Recovery protocol is not an FDA-approved indication for these peptides; it is a compounded-product framework under licensed physician oversight.